Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

LOGIFARMA - LOGÍSTICA FARMACÊUTICA S.A.

NIF 503934640
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €12,872,127 45 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €12,872,127 45 contracts
A2 · Late Publication €17,920,308,580 3,883 contracts
Contract published to BASE more than 10 days after the signing date
LOW €17,920,308,580 3,883 contracts
A5 · Threshold Splitting €70,394,719 131 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €70,394,719 131 contracts
A6 · Low Competition €11,665,936 52 contracts
Only one bidder participated in a competitive procedure
MEDIUM €11,665,936 52 contracts
A9 · Abnormal Price Reduction €20,703,094,522 2,735 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €20,703,094,522 2,735 contracts
C3 · Missing Mandatory Fields €5,374,992 163 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €5,374,992 163 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

303
€1,434,447,842
532
€1,243,722,464
105
€946,887,489
116
€919,641,495
140
€842,540,690
65
€822,325,907
41
€817,046,747
137
€777,132,881
309
€743,753,460
547
€730,060,009
58
€719,189,086
30
€701,942,653
72
€682,533,475
51
€674,054,150
151
€670,205,961
62
€668,125,628
232
€663,126,499
146
€602,216,708
169
€567,431,189
82
€520,000,474
Page 1 of 4 · 73 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 2 of 114 · 5,652 contracts

410312/14SULFATO FERROSO 525 MG COMP LP
PT · 1030285 · Ajuste Direto Regime G...
A2 · Late Publication
€5,201 2014-03-07
MEDICAMENTOS
PT · 1555241 · Ajuste Direto Regime G...
A2 · Late Publication
€32,946 2014-03-20
MEDICAMENTOS CONTRACETIVOS ORAIS PROFILÁTICOS E MECÂNICOS
PT · 1259143 · Ao abrigo de acordo-qu...
A2 · Late Publication
€0 2014-04-10
Contracetivos diversos
PT · f26870f2f324276113b1 · Ao abrigo de acordo-qu...
A2 · Late Publication
€3,055 2014-04-17
Contracetivos diversos
PT · 1630478 · Ao abrigo de acordo-qu...
A2 · Late Publication A9 · Abnormal Price Reduction
€90,058 2014-04-17
Aquisição de 50.000 unidades de desogestrel 0,15 mg + etinilestradiol 0,03 mg comp
PT · 1321030 · Ao abrigo de acordo-qu...
A2 · Late Publication A9 · Abnormal Price Reduction
€1,862,709 2014-04-28
Aquisição de 250.000 unidades de desogestrel 0,15 mg + etinilestradiol 0,02 mg comp
PT · 1321151 · Ao abrigo de acordo-qu...
A2 · Late Publication A9 · Abnormal Price Reduction
€1,862,709 2014-04-28
Aquisição de Desogestrel 0,15MG + Etinilestradiol 0,03MG Comp
PT · 1056324 · Ajuste Direto Regime G...
€3,689 2014-04-29
AQUISIÇÃO DE MEDICAMENTOS
PT · 1543681 · Ajuste Direto Regime G...
A2 · Late Publication
€32,946 2014-04-29
GALSULFASE 1 MG/ML SOL INJ FR 5 ML IV (CPA2013/50)
PT · 1913584 · Ajuste Direto Regime G...
A2 · Late Publication
€32,946 2014-05-05
MEDICAMENTOS DE CONSUMO GERAL: MEDICAÇÃO ANTIALÉRGICA; MEDICAMENTOS USADOS NO TRATAMENTO DE INTOXICAÇÕES E GRUPO 20.9 - OUTRO PRODUTOS 
PT · 1230936 · Ao abrigo de acordo-qu...
A2 · Late Publication A9 · Abnormal Price Reduction
€459,358 2014-05-12
AD para Aquisição de Medicação Antialérgica e para Tratamento de Intoxicações (SPMS 2013/50)
PT · 1437578 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction
€150,019 2014-05-15
CONTRACETIVOS VARIOS - CONTRATO MANDATO - FORNECEDOR LOGIFARMA
PT · 1075803 · Ajuste Direto Regime G...
€105,298 2014-05-20
ICP20130007 - Medicamentos - Ass. Estrógeno-Progestativas p/2014 - Logifarma
PT · 1220357 · Concurso público
A2 · Late Publication A9 · Abnormal Price Reduction
€303,069 2014-05-27
Galsulfase 1 mg/ ml sol inj fr 5 ml IV (CPA 2013/50)
PT · 2231637 · Ajuste Direto Regime G...
A2 · Late Publication
€32,946 2014-07-15
F40037/2014 - OCTENIDINA E FENOXIETANOL (1 MG/ML + 20 MG/ML) GEL
PT · 1567667 · Ajuste Direto Regime G...
A2 · Late Publication
€176 2014-08-11
Galsulfase 1mg/ml Sol Inj Fr 5 Ml IV (CPA2013/50)
PT · 2114908 · Ajuste Direto Regime G...
A2 · Late Publication
€65,892 2014-09-09
F40038/2014 - OCTENIDINA E FENOXIETANOL (1MG/ML+20MG/ML) GEL
PT · 1567864 · Ajuste Direto Regime G...
A2 · Late Publication
€176 2014-09-30
Galsulfase 1 mg/ml Sol inj Fr 5 ml IV (CPA2013/50)
PT · 2127455 · Ajuste Direto Regime G...
A2 · Late Publication
€78,246 2014-10-15
Levonorgestrel 1,5MG Comp
PT · 1286945 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€19,580 2014-10-27
CPA 2013/20 - Levonorgestrel 1,5 mg comp
PT · 1649577 · Ao abrigo de acordo-qu...
A2 · Late Publication
€0 2014-10-28
Desogestrel 0,15MG + Etinilestradiol 0,02MG Comp
PT · 1286584 · Ajuste Direto Regime G...
€17,820 2014-10-29
Aquisição de Galsulfase 1 mg/ml Sol inj Fr 5 ml IV (CPA2013/50)
PT · 1790847 · Ajuste Direto Regime G...
A2 · Late Publication
€10,982 2014-12-05
Ulipristal 5 mg comp
PT · 2433910 · Ajuste Direto Regime G...
A2 · Late Publication
€0 2014-12-10
Galsulfase 1 mg/ml Sol inj Fr 5 ML IV (CPA2013/50)
PT · 1512684 · Ajuste Direto Regime G...
A2 · Late Publication
€36,557 2015-01-21
TRABECTIDINA
PT · 2195403 · Ajuste Direto Regime G...
A2 · Late Publication
€0 2015-01-22
Medicamentos de consumo geral, medicação anti-alérgina, tratamento de intoxicações - C/ Base no CPA 2013/50
PT · 2291174 · Ajuste Direto Regime G...
A2 · Late Publication
€0 2015-01-22
AMIFAMPRIDINA 10 MG COMP
PT · 1426915 · Ajuste Direto Regime G...
A2 · Late Publication
€82,072 2015-01-26
Galsulfase 1 mg/ml sol inj fr 5 ml IV - C/ Base no CPA 2013/50
PT · 2335375 · Ajuste Direto Regime G...
A2 · Late Publication
€0 2015-01-27
Aquisição de Galsulfase
PT · 1365802 · Ao abrigo de acordo-qu...
€336,323 2015-01-28
Aquisição de Trabectidina
PT · 1367533 · Ajuste Direto Regime G...
€0 2015-01-29
Aquisição de Trabectidina 0,25 mg
PT · 1374383 · Ajuste Direto Regime G...
€0 2015-02-05
AD para Aquisição de Ulipristal 5 mg Comp
PT · 1479186 · Ajuste Direto Regime G...
A2 · Late Publication
€247 2015-02-11
ANTINEOPLASICOS E IMUNOMODULADORES
PT · 1397422 · Ajuste Direto Regime G...
A2 · Late Publication
€93,640 2015-02-12
FEXC0095/2015 - VÁRIOS MEDICAMENTOS
PT · 2124044 · Ajuste Direto Regime G...
A2 · Late Publication
€6,344 2015-02-25
Amifampridina 10 mg comp
PT · 2394336 · Ajuste Direto Regime G...
A2 · Late Publication
€0 2015-02-27
Aquisição de Elosulfase
PT · 1441173 · Ajuste Direto Regime G...
A2 · Late Publication
€0 2015-03-04
Contracetivos orais Profiláticos e Mecânicos
PT · 1401520 · Ao abrigo de acordo-qu...
A9 · Abnormal Price Reduction
€37,411 2015-03-05
FEXC0023/2015 - HORMONAS E MEDICAMENTOS USADOS NO TRATAMENTO DAS DOENÇAS ENDÓCRINAS
PT · 2121361 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction
€76,599 2015-03-09
E504 - ETINILESTRADIOL 0,03 mg + DESOSGESTREL (3/6 Ciclos) E506 - ETINILESTRADIOL 0,02 mg + DESOSGESTREL (3/6 ciclos)
PT · 3510127 · Ao abrigo de acordo-qu...
A2 · Late Publication A9 · Abnormal Price Reduction
€87,434 2015-03-10
FEXC0032/2015 - MEDICAMENTOS USADOS EM AFECÇÕES CUTÂNEAS
PT · 1448337 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction
€7,843 2015-03-16
F40025/2015 - MEDICAMENTOS USADOS EM AFECÇÕES CUTÂNEAS
PT · 1450388 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Abnormal Price Reduction
€26,042 2015-03-19
Trabectedina 0,25 mg pó conc sol inj fr IV
PT · 2574980 · Ajuste Direto Regime G...
A2 · Late Publication
€0 2015-03-23
Aquisição de 155.000 emb. de Desogestrel 0,15 mg + Etinilestradiol 0,03 mg, Comp. (3/6 CICLOS); 390.000 emb. de Desogestrel 0,15 mg + Etinilestradiol 0,02 mg, Comp (3/6 CICLOS); 500 Levonorgestrel 1,5 mg, Comp.
PT · 1962368 · Ao abrigo de acordo-qu...
A2 · Late Publication A9 · Abnormal Price Reduction
€3,909,464 2015-03-25
Trabectedina 1 mg pó conc sol inj fr IV
PT · 2623292 · Ajuste Direto Regime G...
A2 · Late Publication
€0 2015-04-02
CONTRATO MANDATO - CONTRACEPTIVOS ORAIS ETINILESTRADIOL 0,03 MG + DESOSGESTREL (E504); ETINILESTRADIOL 0,02 MG + DESOSGESTREL (E506) E LEVONORGESTREL (1,5MG; COMP) (L413)
PT · 1433840 · Ajuste Direto Regime G...
A9 · Abnormal Price Reduction
€79,080 2015-04-10
61/477/2015 - Medicamentos Trabectedina 0.25 mg e 1 mg
PT · 1489265 · Ajuste Direto Regime G...
A2 · Late Publication
€85,816 2015-04-20
61/1884/2015 - Medicamentos - Ulipristal 5 mg
PT · 1494672 · Ajuste Direto Regime G...
A2 · Late Publication
€742 2015-04-20
N CP20140047 - Associações de Estrogenio Progestativas P/2015 - Logifarma
PT · 1450543 · Concurso público
A2 · Late Publication
€134,222 2015-04-22
FEXC0111/2015 - TRABECTEDINA 1 MG PO CONC SOL INJ FR
PT · 2124052 · Ajuste Direto Regime G...
A2 · Late Publication
€55,832 2015-04-27
← Prev Next →
Overview
Total Value Won
€20,881,085,820
Contracts Won
5,652
Score 193805 · CRITICAL RISK
NIF
503934640
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.M. [P-5f49]
    Vogal
    since 2019-02-12
  • C.D. [P-dec9]
    Vogal
    since 2025-05-28
  • D.P. [P-47c1]
    Vogal
    since 2025-05-28
  • I.D. [P-13ce]
    Vogal
    since 2008-12-03
  • I.D. [P-13ce]
    Vogal
    since 2011-10-12
  • I.D. [P-13ce]
    vogal
    since 2017-05-31
  • J.P. [P-951b]
    Presidente
    since 2025-05-28
  • M.M. [P-e084]
    Vogal
    since 2019-02-12
  • M.M. [P-e084]
    Vogal
    since 2023-04-14
  • M.P. [P-69a5]
    Vogal
    since 2020-04-23
  • P.M. [P-3b93]
    Presidente
    since 2008-12-03
  • P.M. [P-3b93]
    Presidente
    since 2011-10-12
  • P.M. [P-3b93]
    presidente
    since 2017-05-31
  • R.M. [P-2778]
    Presidente
    since 2022-09-12
  • R.M. [P-2778]
    Presidente
    since 2023-04-14
  • R.D. [P-1f13]
    Vogal
    since 2008-12-03
  • R.D. [P-1f13]
    Vogal
    since 2011-10-12
  • A.J. [P-bc9f]
    Fiscal Único
    since 2008-12-03
  • A.J. [P-bc9f]
    Fiscal Único
    since 2011-10-12
  • D.A. [P-c2b1]
    Fiscal Único
    since 2019-02-12
  • D.A. [P-c2b1]
    Fiscal Único
    since 2023-04-14
  • J.C. [P-75e0]
    Fiscal Único
    since 2023-04-14
  • P.A. [P-2d72]
    Fiscal Único
    since 2019-02-12
  • U.A. [P-6b22]
    Fiscal Único
    since 2008-12-03
  • U.A. [P-6b22]
    Fiscal Único
    since 2011-10-12
  • A.M. [P-5f49]
    Vogal
    2023-04-14 → 2024-11-28
  • C.D. [P-54e9]
    Vogal
    2019-02-12 → 2020-04-23
  • F.M. [P-351d]
    Vogal
    2024-11-28 → 2025-05-27
  • I.D. [P-13ce]
    Vogal
    2019-02-12 → 2019-02-12
  • I.D. [P-13ce]
    Vogal
    2023-04-14 → 2024-12-09
  • J.P. [P-9310]
    Vogal
    2025-11-17 → 2026-01-14
  • M.M. [P-e084]
    Vogal
    2025-05-28 → 2025-05-28
  • M.M. [P-e084]
    Vogal
    until 2025-11-13
  • M.A. [P-6e88]
    Vogal
    2023-04-14 → 2025-05-28
  • P.J. [P-7343]
    Presidente
    2019-02-12 → 2021-09-10
  • P.M. [P-976f]
    Vogal
    2023-04-14 → 2025-01-08
  • P.M. [P-3b93]
    Vogal
    2019-02-12 → 2019-02-12
  • P.M. [P-3b93]
    Vogal
    2023-04-14 → 2024-12-09
  • R.M. [P-2778]
    Vogal
    2025-05-28 → 2025-05-28
  • R.M. [P-2778]
    Vogal
    until 2026-01-14
  • R.D. [P-1f13]
    vogal
    2017-05-31 → 2019-02-12
  • T.G. [P-26e1]
    Vogal
    2019-02-12 → 2022-02-04
  • A.J. [P-bc9f]
    Fiscal Único
    2017-05-31 → 2019-02-12
  • U.A. [P-6b22]
    Fiscal Único
    2017-05-31 → 2019-02-12
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned